Citic-controlled Harbin Pharmaceutical To Invest $300M In US Wellness Company GNC, Becoming Biggest Shareholder

Login to View

Citic Capital-controlled Harbin Pharmaceutical Group Holding, known as Hayao, has agreed to invest US$300 million in U.S.-based health and wellness retailer GNC Holdings, becoming the single largest shareholder in NYSE-traded GNC.

China Money Network

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech


Read 2 Articles for Free with a Basic Account

Gain limited and restricted access to China Money Network.

Register Basic Account

Subscribe for an annual subscription!

Enjoy comprehensive and exclusive data you can't find elsewhere!

More Info


Subscribe and Pay Easily Online!

Already have an account or paid subscription? Log in

China Money Network Subscription

RELATED NEWS